About Michael Levy, MD, PhD
Dr. Michael Levy, MD, PhD, is the Research Director of the Division of Neuroimmunology & Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine (Houston, TX) with a focus on neuroscience. Dr. Levy completed his Johns Hopkins internship in the Osler Medicine program, residency in the Johns Hopkins Neurology program and a fellowship in Neuroimmunology at Johns Hopkins University. In 2009, Dr. Levy was appointed to the faculty as Assistant Professor at Johns Hopkins where he started the Neuromyelitis Optica Clinic and Research Laboratory and in 2019 he moved to the Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology.
Clinically, Dr. Levy specializes in taking care of patients with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease, acute disseminated encephalomyelitis and optic neuritis. In addition to neuroimmunology clinics, Dr. Levy has a special interest in patients with superficial siderosis of the central nervous system. Dr. Levy is the principal investigator on several clinical studies and drug trials for all of these conditions.
Appointed the Research Director of the Division of Neuroimmunology & Neuroinfectious Disease at Massachusetts General Hospital, Dr. Levy is focused on understanding how the immune system and the nervous system interact to cause disease. This includes autoimmune diseases, such as neuromyelitis optica, in which the immune system is aberrantly responding to a harmless trigger, as well as Parkinsons and Alzheimer's disease in which the immune system might be reacting to a trigger in the neural environment. In his lab, they use genetically modified mice to model these neuroimmunological interactions and then develop strategies to re-educate the immune system towards a better outcome.
Clinical Interests:
- Acute Disseminated Encephalomyelitis (ADEM)
- Autoimmune Encephalitis
- Autoimmune neurologic conditions
- Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neurosarcoidosis
- Optic neuritis
- Superficial Siderosis
- Transverse myelitis
Treats:
- Adult & Pediatrics
Locations
Mass General Neurology
55 Fruit St.
Boston, MA 02114
Phone: 617-726-7565
Fax: 888-523-4168
Medical Education
- M.D.; Ph.D., Baylor College Of Medicine
- Fellowship, Johns Hopkins Hospital***
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
The Levy Lab is focused on understanding the immunopathogenic mechanisms of rare autoimmune diseases of the central nervous system including neuromyelitis optica, transverse myelitis and MOG antibody disease. We have expertise in animal models of these diseases which we also use to study pathogenic mechanisms of autoimmunity. The goal to translate our findings to human trials is driven by the unmet need in the neuroimmunology clinic.